| Mr Todd L Chidester, FNP | |
|
1159 E 200 N Suite 200, American Fork, UT 84003 | |
| (801) 756-5290 | |
| (801) 756-5200 |
| Full Name | Mr Todd L Chidester |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 1159 E 200 N Suite 200, American Fork, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154383305 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 195992-8900 (Utah) | Secondary |
| 363LP0200X | Nurse Practitioner - Pediatrics | 195992-4405 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Todd L Chidester, FNP 1159 E 200 N Suite 200, American Fork, UT 84003 Ph: (801) 756-5290 | Mr Todd L Chidester, FNP 1159 E 200 N Suite 200, American Fork, UT 84003 Ph: (801) 756-5290 |
News Archive
A protein that helps lung cancer cells thrive appears to do so by blocking healthy cells' ability to fix themselves when radiation or chemicals such as nicotine damage their DNA, according to a University of Florida study to be published Friday (Feb. 29) in the journal Molecular Cell.
A new study by Australia's national science agency, CSIRO, has found that weight and emotional wellbeing has suffered throughout the COVID-19 lockdown, with Australians also feeling concerned about how long it will take for life to return to "normal".
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
African-Americans know the signs of stroke, but concerns about medical cost, ambulance response time and unfamiliarity with the need for prompt hospital care impacted whether they called 9-1-1 immediately.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an indication extension to the European Medicines Agency for the approval of Erbitux in combination with standard 1st line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer with high epidermal growth factor receptor expression.
› Verified 3 days ago
Andrew Olesen, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 922 Nob Hill Ave, American Fork, UT 84003 Phone: 801-471-0951 | |
Sandra Burkinshaw, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1248 E 90 N, Suite 300, American Fork, UT 84003 Phone: 801-756-9635 | |
Sarah Prentice, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 226 N 1100 E, American Fork, UT 84003 Phone: 801-855-3841 | |
Joseph Woodruff Palmer, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1175 E 50 S Ste 171, American Fork, UT 84003 Phone: 801-772-0698 Fax: 801-772-0705 | |
Mr. Orrin Blake Hansen, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 241, American Fork, UT 84003 Phone: 801-492-5999 Fax: 801-418-0897 | |
Hayley Alece Jolley, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1248 E 90 N Ste 103, American Fork, UT 84003 Phone: 801-852-9560 |